
|Videos|September 7, 2021
Dr. Sarah Faris assesses tramadol and alternatives to opioid prescriptions
Author(s)Urology Times staff
“We have to be really careful prescribing tramadol and be aware that [it] can have really variable effects for patients,” says Sarah F. Faris, MD.
Advertisement
In this video, Sarah F. Faris, MD, discusses the risk of prescribing tramadol to patients and how her institution is currently developing ERAS pathways to minimize those prescriptions. Faris is an associate professor of surgery at the University of Chicago, Illinois.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA provides guidance on development pathway for testosterone therapy for women
2
Pearls & Perspectives: Leadership and Prostate Cancer, with Mark L. Gonzalgo, MD, PhD, MBA
3
Treatment Selection in Advanced Prostate Cancer
4
Pedro Freitas, MD, on consolidative surgery vs prolonged systemic therapy in MIBC
5






